G
Graham J. Ray
Researcher at University of California, Berkeley
Publications - 8
Citations - 1277
Graham J. Ray is an academic researcher from University of California, Berkeley. The author has contributed to research in topics: Cas9 & DNA. The author has an hindex of 6, co-authored 8 publications receiving 1013 citations.
Papers
More filters
Journal ArticleDOI
Enhancing homology-directed genome editing by catalytically active and inactive CRISPR-Cas9 using asymmetric donor DNA
TL;DR: By rationally designing single-stranded DNA donors of the optimal length complementary to the strand that is released first, this work increases the rate of HDR in human cells when using Cas9 or nickase variants to up to 60%.
Journal ArticleDOI
Discovery of stimulation-responsive immune enhancers with CRISPR activation
Dimitre R. Simeonov,Benjamin G. Gowen,Mandy Boontanrart,Theodore L. Roth,John D. Gagnon,Maxwell R. Mumbach,Ansuman T. Satpathy,Youjin Lee,Youjin Lee,Nicolas Bray,Alice Y. Chan,Dmytro Lituiev,Michelle L.T. Nguyen,Michelle L.T. Nguyen,Rachel E. Gate,Meena Subramaniam,Zhongmei Li,Zhongmei Li,Jonathan M. Woo,Jonathan M. Woo,Therese Mitros,Graham J. Ray,Gemma L. Curie,Nicki Naddaf,Julia S. Chu,Hong Ma,Eric Boyer,Eric Boyer,Frédéric Van Gool,Hailiang Huang,Hailiang Huang,Ruize Liu,Ruize Liu,Victoria Tobin,Victoria Tobin,Kathrin Schumann,Kathrin Schumann,Mark J. Daly,Mark J. Daly,Kyle Kai-How Farh,K. Mark Ansel,Chun Jimmie Ye,William J. Greenleaf,Mark S. Anderson,Jeffrey A. Bluestone,Howard Y. Chang,Jacob E. Corn,Alexander Marson +47 more
TL;DR: A discovery platform that can identify stimulus-responsive enhancers for a target gene independent of stimulus exposure is described and reveals how non-coding variation associated with human immune dysfunction alters context-specific gene programs.
Journal ArticleDOI
Non-homologous DNA increases gene disruption efficiency by altering DNA repair outcomes.
TL;DR: It is found that non-homologous single-stranded DNA greatly stimulates Cas9-mediated gene disruption in the absence of homology-directed repair, dramatically increasing the frequency of gene disruption.
Patent
Compositions and methods for enhanced genome editing
TL;DR: In this paper, the authors provide methods and compositions for enhanced editing of genomic DNA, including linearized non-homologous DNA composition and a genome targeting composition (which includes a genome editing endonuclease, or a nucleic acid encoding the genome-e.g., a CRISPR/Cas guide RNA).
Posted ContentDOI
Non-homologous DNA increases gene disruption efficiency by altering DNA repair outcomes
TL;DR: It is found that linear, non-homologous oligonucleotide DNA greatly stimulates Cas9-mediated gene disruption in the absence of homology-directed repair, dramatically increasing the frequency of gene disruption.